CODX vs JLL · rev $3.9M vs P/E 23, rev $23.43B
Co-Diagnostics, Inc. Common Stock (CODX) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported JLL revenue for 2024-12-31 was $23.43B. Net income was $546.8M. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
CODX currently screens at market cap $31.4M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the CODX and JLL stock pages for the full models.
Not investment advice.